Delivery Order HHSN271201700016I-75N95018F00003
Award Date
7/15/18
Potential Completion Date
2/28/19
Potential Value
$130K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
IIT Research Institute
Ultimate Awardee
Illinois Institute Of Technology
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $913,177 delivery order against its CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract to IIT Research Institute. IIT Research Institute, operating as the research and programs division of the Illinois Institute of Technology, will conduct three-month subcutaneous toxicity studies in dogs and mice to support the Center's drug development programs. Performance will...
This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to IIT Research Institute, a non-profit organization and the research and technology development arm of Illinois Institute of Technology. The $547,622.10 cost-plus-fixed-fee contract is for a 28-day topical eye toxicity study of the drug candidate ACT-1 in dogs, with a 14-day recovery period. This work supports NCATS' in...
This is a delivery order awarded by the Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences (NCATS) to IIT Research Institute, a non-profit research arm of Illinois Institute of Technology. The $1,759,590.00 cost-plus-fixed-fee contract provides non-clinical safety assessment of drinabant, a cannabinoid receptor (CB-1) antagonist, for acute cannabinoid overdose. The work will be performed in Chicago, Illinois and is part of...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $271,488 delivery order against its CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract to IIT Research Institute. IIT Research Institute, a division of the Illinois Institute of Technology, will provide in vitro and in vivo toxicology studies support services to NCATS under cost-plus-fixed-fee pricing from June 2018 through August 2019. The prime contractor will...
This is a $2,495,455.00 delivery order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology. The contract is for non-clinical safety assessment of a covalent bi-tox compound to support a neuropathic pain indication. This delivery order is part of a larger $48.6 million multiple-award CRO Support for NCATS In Vitro and...
This is a federal contract awarded by the U.S. Department of Health and Human Services (HHS) to the Illinois Institute of Technology Research Institute (IITRI), a non-profit contract research organization. The contract, valued at $231,502, is for preclinical toxicology studies of chemopreventive agents in dogs under work order #62. The contract is a definitive, firm-fixed price contract with a completion date of June 30, 2005. IITRI specializes in conducting pharmacology, toxicology, safety, and...
IIT Research Institute was awarded a $1.57 million cost-plus-fixed-fee delivery order against the CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract by the National Institutes of Health's National Center for Advancing Translational Sciences. The task order is for non-clinical safety assessment of SPIF to support the chronic graft-versus-host disease indication. Work will be performed in Chicago, Illinois through November 2020. IIT Research Institute will conduct...
This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $119,495.00 firm fixed-price Purchase Order is for a 14-day dose range finding study in mice to support Investigational New Drug (IND) applications. IITRI has extensive experience conducting preclinical drug development services, including toxicology,...
This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and...
This is a $631,772.00 delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for toxicology studies on reproductive effects in rats, supporting the NCCIH (National Center for Complementary and Integrative Health) program. This is a cost-plus-fixed-fee contract that was not set aside for any type of small...